2019 U.S.-Booked Air Volume: $54 million
BTN estimates U.S.-booked air volume at AbbVie decreased from $62 million to $54 million in 2019, the second successive year that air spend is believed to have fallen. Revenues at the biopharmaceuticals company, whose specializations include immunology, oncology and neuroscience, rose 1.6 percent to $33.2 billion. In May 2020, AbbVie completed its acquisition of Allergan, a fellow entrant in the BTN CT100. The addition of Allergan has increased the number of employees at AbbVie from 30,000 in 2018 to 47,000 today, with manufacturing and research facilities in 14 countries. Combined revenue following the acquisition is $50 billion. In response to the coronavirus pandemic, AbbVie said it introduced “strict travel restrictions in accordance with government guidance.”